Literature DB >> 3569737

Low dose omeprazole effects on gastric acid secretion in normal man.

P Hemery, J P Galmiche, C Roze, J P Isal, S Bruley des Varannes, A Lavignolle, L Le Bodic.   

Abstract

The pharmacological effects of low dose of omeprazole (Om) are not well known. This prompted us to investigate the effects of a 7-day treatment with a low dose of Om, 10 mg/d (Om10), on gastric acid secretion and serum gastrin levels and to compare the results with those obtained with an effective antisecretory dose of 20 mg/d (Om20). Twelve healthy volunteers received randomly and double-blind for three periods of 7 days, separated by at least 7 days, one capsule of placebo (P), Om10, Om20, given daily in the morning, in fasting condition. The last day of each period, 24 h pH was recorded using a glass electrode connected to a Digitrapper (Synectics). At the end of each pH-metry, acid secretion was measured in basal conditions (BAO), after sham-feeding (SAO) and after i.m. injection of 6 micrograms X kg-1 of pentagastrin (PAO). Whatever the threshold pH chosen, there was a statistically significant difference between P and Om10, P and Om20, and Om10 and Om20. Inhibition of acid concentrations was dose-dependent and prolonged, including nocturnal time. However, when considered on an individual basis, five subjects did not respond to Om10. More than 24 h after the last dose of Om has been administered, BAO, SAO and PAO were significantly reduced by either Om10 (respectively -52, -35 and -28 p. cent) and Om20 (respectively -60, -58 and -50 p. cent). Fasting serum gastrin concentration was significantly increased after Om20 treatment but not after Om10. We conclude that treatment with Om10 has a consistent and long lasting inhibitory action on gastric acidity without statistically significant effect on serum gastrin levels. These results suggest that 10 mg Om daily should be sufficient in some duodenal ulcer patients to effectively inhibit gastric acidity specially when long-term treatment seems to be indicated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569737

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  6 in total

1.  Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.

Authors:  P Hemery; P Congard; J P Galmiche; S Bonfils
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.

Authors:  K D Bardhan; P Cherian; A Vaishnavi; R B Jones; M Thompson; P Morris; A Brooks; J D'Silva; K R Gillon; C Wason; J Patterson; J Polak; A Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

3.  Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; D Perilli; A Vassallo; A Zambotti; C Mansi; G Celle
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 4.  Omeprazole. Gastrin and gastric endocrine cell data from clinical studies.

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

5.  Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; S Vigneri; G Celle
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

6.  Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.

Authors:  C M Bate; S N Booth; J P Crowe; R A Mountford; P W Keeling; B Hepworth-Jones; M D Taylor; P D Richardson
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.